Nurix
Jenny McKinnell has a wealth of experience in bioanalytical chemistry, pharmacokinetics, and drug development. Jenny has worked in various roles at companies such as Nurix Therapeutics, RAPT Therapeutics, Genentech, Achaogen, Theravance, and more. Jenny's expertise includes LC-MS/MS methods development, in vitro studies, plasma protein binding, and managing PK studies. Jenny has a Bachelor of Science degree in Clinical Science from San Francisco State University. Throughout their career, Jenny has demonstrated a strong ability to develop analytical methods, conduct data analysis, and collaborate with various teams to contribute to the advancement of scientific research.
Nurix
3 followers
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.